Purification of Antimicrobial Peptides from Human Skin

Part of the Methods in Molecular Biology book series (MIMB, volume 618)


Human skin is a rich source of human antimicrobial peptides. Its cellular source is the keratinocyte, which terminally differentiates in the uppermost parts of the skin, eventually forming the stratum corneum, the horny layer. The easy availability of human stratum corneum makes it possible to identify and characterize human antimicrobial peptides with a biochemical approach. Moreover, the availability of lesional scales of patients with psoriasis, an inflammatory skin disease, allows the identification of human-inducible peptide antibiotics, which are absent in healthy skin. With this strategy, the beta-defensins hBD-2 and hBD-3, RNase-7 as well as psoriasin/S100A7 have been discovered as human antimicrobial peptides and proteins. A detailed description of the strategies and methods is presented, which allowed a successful identification and characterization of human antimicrobial peptides. We used various HPLC techniques, combined with antimicrobial testing as read-out system. In parallel, SDS-PAGE analyses as well as electrospray ionization mass spectrometry were used for further biochemical characterization as well as purity assessment.

Key words

Antimicrobial peptides defensin RNase-7 S100A7 skin stratum corneum purification electrospray ionization mass spectrometry high-performance liquid chromatography 


  1. 1.
    Steinberg, D. A. and Lehrer, R. I. (1997) Designer assays for antimicrobial peptides. Disputing the “one-size-fits-all” theory. Methods Mol. Biol. 78(1), 69–186.Google Scholar
  2. 2.
    Ganz, T., Metcalf, J. A., Gallin, J. I., Boxer, L. A., and Lehrer, R. I. (1988) Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and “specific” granule deficiency. J Clin. Invest. 82, 552–556.PubMedCrossRefGoogle Scholar
  3. 3.
    Schägger, H. and von Jagow, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368–379.PubMedCrossRefGoogle Scholar
  4. 4.
    Harder, J., Bartels, J., Christophers, E., and Schröder, J. M. (1997) A peptide antibiotic from human skin. Nature 387, 861.PubMedCrossRefGoogle Scholar
  5. 5.
    Harder, J., Bartels, J., Christophers, E., and Schröder, J. M. (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707–5713.PubMedCrossRefGoogle Scholar
  6. 6.
    Harder, J. and Schröder, J. M. (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277, 46779–46784.PubMedCrossRefGoogle Scholar
  7. 7.
    Schröder, J. M. (2000) Purification of chemokines from natural sources. Methods Mol. Biol. 138, 1–10.PubMedGoogle Scholar
  8. 8.
    Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E., and Schröder, J. M. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6, 57–64.PubMedCrossRefGoogle Scholar
  9. 9.
    Schröder, J. M., Mrowietz, U., Morita, E., and Christophers, E. (1987) Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol. 139, 3474–3483.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Clinical Research Unit “Cutaneous Inflammation”, Department of DermatologyUniversity Hospital Schleswig-HolsteinKielGermany

Personalised recommendations